These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 23577151)

  • 1. Expression of miR-142-5p in peripheral blood mononuclear cells from renal transplant patients with chronic antibody-mediated rejection.
    Danger R; Paul C; Giral M; Lavault A; Foucher Y; Degauque N; Pallier A; Durand M; Castagnet S; Duong Van Huyen JP; Delahousse M; Renaudin K; Soulillou JP; Brouard S
    PLoS One; 2013; 8(4):e60702. PubMed ID: 23577151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-142-5p and miR-486-5p as biomarkers for early detection of chronic antibody-mediated rejection in kidney transplantation.
    Iwasaki K; Yamamoto T; Inanaga Y; Hiramitsu T; Miwa Y; Murotani K; Narumi S; Watarai Y; Katayama A; Uchida K; Kobayashi T
    Biomarkers; 2017 Feb; 22(1):45-54. PubMed ID: 27323802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A type I interferon signature characterizes chronic antibody-mediated rejection in kidney transplantation.
    Rascio F; Pontrelli P; Accetturo M; Oranger A; Gigante M; Castellano G; Gigante M; Zito A; Zaza G; Lupo A; Ranieri E; Stallone G; Gesualdo L; Grandaliano G
    J Pathol; 2015 Sep; 237(1):72-84. PubMed ID: 25925804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential expression of microRNAs in renal transplant patients with acute T-cell mediated rejection.
    Soltaninejad E; Nicknam MH; Nafar M; Ahmadpoor P; Pourrezagholi F; Sharbafi MH; Hosseinzadeh M; Foroughi F; Yekaninejad MS; Bahrami T; Sharif-Paghaleh E; Amirzargar A
    Transpl Immunol; 2015 Sep; 33(1):1-6. PubMed ID: 26002284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Immune Profiles and MicroRNA Expression Profiles in Peripheral Blood Mononuclear Cells of Long-Term Stable Liver Transplant Recipients and Recipients With Acute Rejection Episodes.
    Zhang P; Guo Z; Zhong K; Li Q; Ouyang J; Chen M; Hu A; Jiao X; Zhu X; He X
    Transplant Proc; 2015 Dec; 47(10):2907-15. PubMed ID: 26707312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of T Cell-Mediated Vascular Rejection After Kidney Transplantation by the Combined Measurement of 5 Specific MicroRNAs in Blood.
    Matz M; Fabritius K; Lorkowski C; Dürr M; Gaedeke J; Durek P; Grün JR; Goestemeyer A; Bachmann F; Wu K; Rudolph B; Schmidt D; Weber U; Haftmann C; Unterwalder N; Lachmann N; Radbruch A; Neumayer HH; Mashreghi MF; Budde K
    Transplantation; 2016 Apr; 100(4):898-907. PubMed ID: 26444957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrarenal Complement System Transcripts in Chronic Antibody-Mediated Rejection and Recurrent IgA Nephropathy in Kidney Transplantation.
    Cernoch M; Hruba P; Kollar M; Mrazova P; Stranavova L; Lodererova A; Honsova E; Viklicky O
    Front Immunol; 2018; 9():2310. PubMed ID: 30356754
    [No Abstract]   [Full Text] [Related]  

  • 8. Altered Phosphorylation of Cytoskeleton Proteins in Peripheral Blood Mononuclear Cells Characterizes Chronic Antibody-Mediated Rejection in Kidney Transplantation.
    Rocchetti MT; Rascio F; Castellano G; Fiorentino M; Netti GS; Spadaccino F; Ranieri E; Gallone A; Gesualdo L; Stallone G; Pontrelli P; Grandaliano G
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32899575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered Expression of MicroRNAs Following Chronic Allograft Dysfunction with Interstitial Fibrosis and Tubular Atrophy.
    Soltaninejad E; Nicknam MH; Nafar M; Sharbafi MH; Keshavarz Shahbaz S; Barabadi M; Yekaninejad MS; Bahrami T; Ahmadpoor P; Amirzargar A
    Iran J Allergy Asthma Immunol; 2015 Dec; 14(6):615-23. PubMed ID: 26725559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TLR-2, TLR-4 and MyD88 genes expression in renal transplant acute and chronic rejections.
    Sharbafi MH; Assadiasl S; Pour-Reza-Gholi F; Barzegari S; Mohammadi Torbati P; Samavat S; Nicknam MH; Amirzargar A
    Int J Immunogenet; 2019 Dec; 46(6):427-436. PubMed ID: 31286693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrative Omics Analysis Unravels Microvascular Inflammation-Related Pathways in Kidney Allograft Biopsies.
    Tinel C; Lamarthée B; Callemeyn J; Van Loon E; Sauvaget V; Morin L; Aouni L; Rabant M; Gwinner W; Marquet P; Naesens M; Anglicheau D
    Front Immunol; 2021; 12():738795. PubMed ID: 34795664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring of miR-181a-5p and miR-155-5p Plasmatic Expression as Prognostic Biomarkers for Acute and Subclinical Rejection in
    Millán O; Ruiz P; Orts L; Ferré P; Crespo G; Santana M; Fortuna V; Quintairos L; Navasa M; Brunet M
    Front Immunol; 2019; 10():873. PubMed ID: 31068943
    [No Abstract]   [Full Text] [Related]  

  • 13. Peripheral blood immune response-related gene analysis for evaluating the potential risk of chronic antibody-mediated rejection.
    Yamamoto T; Iwasaki K; Murotani K; Takeda A; Futamura K; Okada M; Tsujita M; Hiramitsu T; Goto N; Narumi S; Watarai Y; Morozumi K; Uchida K; Kobayashi T
    Hum Immunol; 2018 Jun; 79(6):432-438. PubMed ID: 29614336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulation of microRNA 142-3p in the peripheral blood and urinary cells of kidney transplant recipients with post-transplant graft dysfunction.
    Domenico TD; Joelsons G; Montenegro RM; Manfro RC
    Braz J Med Biol Res; 2017 Apr; 50(4):e5533. PubMed ID: 28380212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Ratio of CD226 and TIGIT Expression in Tfh and PD-1
    Fan JW; Fan Y; Wan ZL; Yan L; Li YM; Bai YJ; Wang LL; Chen J; Li Y
    J Immunol Res; 2022; 2022():5326083. PubMed ID: 35733922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary miR-155-5p and CXCL10 as prognostic and predictive biomarkers of rejection, graft outcome and treatment response in kidney transplantation.
    Millán O; Budde K; Sommerer C; Aliart I; Rissling O; Bardaji B; Matz M; Zeier M; Silva I; Guirado L; Brunet M
    Br J Clin Pharmacol; 2017 Dec; 83(12):2636-2650. PubMed ID: 28880456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinical and genomic significance of donor-specific antibody-positive/C4d-negative and donor-specific antibody-negative/C4d-negative transplant glomerulopathy.
    Hayde N; Bao Y; Pullman J; Ye B; Calder RB; Chung M; Schwartz D; Lubetzky M; Ajaimy M; de Boccardo G; Akalin E
    Clin J Am Soc Nephrol; 2013 Dec; 8(12):2141-8. PubMed ID: 24030736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antagonism of profibrotic microRNA-21 improves outcome of murine chronic renal allograft dysfunction.
    Schauerte C; Hübner A; Rong S; Wang S; Shushakova N; Mengel M; Dettling A; Bang C; Scherf K; Koelling M; Melk A; Haller H; Thum T; Lorenzen JM
    Kidney Int; 2017 Sep; 92(3):646-656. PubMed ID: 28396121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA regulation in blood cells of renal transplanted patients with interstitial fibrosis/tubular atrophy and antibody-mediated rejection.
    Matz M; Heinrich F; Lorkowski C; Wu K; Klotsche J; Zhang Q; Lachmann N; Durek P; Budde K; Mashreghi MF
    PLoS One; 2018; 13(8):e0201925. PubMed ID: 30102719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential urinary extracellular vesicle protein biomarkers of chronic active antibody-mediated rejection in kidney transplant recipients.
    Jung HY; Lee CH; Choi JY; Cho JH; Park SH; Kim YL; Moon PG; Baek MC; Berm Park J; Hoon Kim Y; Ha Chung B; Lee SH; Kim CD
    J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Feb; 1138():121958. PubMed ID: 31918306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.